To determine the chronology of postnatal somatostatin (SRIF) changes i
n preterm infants and the relationship of SRIF levels to respiratory a
nd gastrointestinal complications, we evaluated sequential SRIF levels
in 62 preterm infants in the first month of life. Weekly preprandial
plasma samples were obtained and analyzed for SRIF using a radioimmuno
assay. Additional blood samples were obtained at the time of abdominal
events. Somatostatin levels were highest in week 2 and gradually decl
ined in weeks 3 and 4 (mean +/- SD pmol/l, SRIF = 92.3 +/- 30.3 in wee
k 2 vs. 79.8 +/- 33.9 in week 3 and 69.7 +/- 54.4 in week 4, p < 0.03)
. Birth weight, gestational age and sex were not related to initial SR
IF levels. Infants with respiratory distress requiring assisted ventil
ation had significantly higher week 1 SRIF levels compared to infants
without respiratory problems (97.9 +/- 22.7 vs. 74.9 +/- 21 pmol/l, p
< 0.02). Twenty-one of the 62 infants had gastrointestinal complicatio
ns. Somatostatin levels preceding (89.0 +/- 25.9 pmol/l), during(91.0
+/- 13.3) and after (79.3 +/- 28.6) the gastrointestinal events were n
ot significantly different, nor were they different from SRIF concentr
ations of age-matched preterm infants without gastrointestinal complic
ations. The results suggest that in preterm infants, postnatal SRIF ch
anges follow a definite pattern with peak concentrations in week 2. Re
spiratory distress is associated with a significant increase in SRIF.
However, subsequent gastrointestinal events do not lead to an increase
in SRIF. This lack of SRIF response in gastrointestinal stress may pl
ay a role in the pathogenesis of gut injury in the premature neonate.